Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the coronary stents devices market, including market shares of different players within Finland. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Finland Coronary Stents Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the coronary stents market in Finland was Medtronic followed by Boston Scientific, Abbott Laboratories, B. Braun Melsungen, Biotronik SE, Lepu Medical Technology (Beijing), Vascular Concepts, Meril Life Sciences, Sahajanand Medical Technologies, Translumina Therapeutics and MicroPort Scientific.

The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent system consists of a stent and balloon catheter delivery system. Coronary bare metal stents are uncoated stents that are permanently placed inside the artery. Coronary drug eluting stents release drugs locally and can be coated with a polymeric material. Coronary covered stents have a metal skeleton with an extra accessory or cover which is made up of fabric or graft material. Coronary bioabsorbable stents are also known as bioresorbable or biodegradable coronary stents.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the coronary stents devices market within Finland was expected to be over $10m in 2022.

For the latest complete market share analysis of coronary stents device market in Finland, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.